{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:55:17Z","timestamp":1793922917998,"version":"4.8.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00428-019-02633-6","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T07:02:26Z","timestamp":1564470146000},"page":"671-686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Update on polyglucosan storage diseases"],"prefix":"10.1007","volume":"475","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5824-3118","authenticated-orcid":false,"given":"Giovanna","family":"Cenacchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Marozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,30]]},"reference":[{"key":"2633_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bbagen.2004.03.017","volume":"1673","author":"J Lomako","year":"2004","unstructured":"Lomako J, Lomako WM, Whelan WJ (2004) Glycogenin: the primer for mammalian and yeast glycogen synthesis. Biochim Biophys Acta 1673:45\u201355","journal-title":"Biochim Biophys Acta"},{"key":"2633_CR2","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/iub.254","volume":"61","author":"WJ Whelan","year":"2009","unstructured":"Whelan WJ (2009) My favourite enzyme. Glycogenin. IUBMD Life 61:1099\u20131100","journal-title":"IUBMD Life"},{"key":"2633_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/0014-5793(94)80580-6","volume":"342","author":"MD Alonso","year":"1994","unstructured":"Alonso MD, Lomako J, Lomako WM, Whelan WJ (1994) Tyrosine-194 of glycogenin undergoes autocatalytic glucosylation but is not essential for catalytic function and activity. FEBS Lett 342:38\u201342","journal-title":"FEBS Lett"},{"key":"2633_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/TACG.S57890","volume":"9","author":"M Kecmanovic","year":"2016","unstructured":"Kecmanovic M, Keckarevic-Markovic M, Keckarevic D et al (2016) Genetics of Lafora progressive myoclonic epilepsy: current perspectives. Appl Clin Genet 9:49\u201353","journal-title":"Appl Clin Genet"},{"key":"2633_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10545-014-9785-5","volume":"38","author":"MW Kilimann","year":"2015","unstructured":"Kilimann MW, Oldfors A (2015) Glycogen pathways in disease: new developments in a classical field of medical genetics. J Inherit Metab Dis 38:483\u2013487","journal-title":"J Inherit Metab Dis"},{"key":"2633_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.nmd.2006.05.259","volume":"16","author":"BA Valentine","year":"2006","unstructured":"Valentine BA, Cooper BJ (2006) Development of polyglucosan inclusions in skeletal muscle. Neuromuscul Disord 16:603\u2013607","journal-title":"Neuromuscul Disord"},{"key":"2633_CR7","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1111\/j.1742-4658.2011.08287.x","volume":"278","author":"R Puri","year":"2011","unstructured":"Puri R, Jain N, Ganesh S (2011) Increased glucose concentration results in reduced proteasomal activity and the formation of glycogen positive aggresomal structures. FEBS J 278:3688\u20133698","journal-title":"FEBS J"},{"key":"2633_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/nan.12171","volume":"41","author":"M Fanin","year":"2015","unstructured":"Fanin M, Nascimbeni AC, Savarese M, Papa V, Cenacchi G, Nigro V, Angelini C (2015) Familial polyglucosan body myopathy with unusual phenotype. Neuropathol Appl Neurobiol 41:385\u2013390","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2633_CR9","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.bbadis.2008.10.011","volume":"1782","author":"AJ Murton","year":"2008","unstructured":"Murton AJ, Constantin D, Greenhaff PL (2008) The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim Biophys Acta 1782:730\u2013743","journal-title":"Biochim Biophys Acta"},{"key":"2633_CR10","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1093\/hmg\/ddr590","volume":"21","author":"O Criado","year":"2012","unstructured":"Criado O, Aguado C, Gayarre J, Duran-Trio L, Garcia-Cabrero AM, Vernia S, San Mill\u00e1n B, Heredia M, Rom\u00e1-Mateo C, Mouron S, Juana-L\u00f3pez L, Dom\u00ednguez M, Navarro C, Serratosa JM, Sanchez M, Sanz P, Bovolenta P, Knecht E, Rodriguez de Cordoba S (2012) Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy. Hum Mol Genet 21:1521\u20131533","journal-title":"Hum Mol Genet"},{"key":"2633_CR11","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/WCO.0b013e328364dbdc","volume":"26","author":"A Oldfors","year":"2013","unstructured":"Oldfors A, DiMauro S (2013) New insights in the field of muscle glycogenosis. Curr Opin Neurol 26:544\u2013553","journal-title":"Curr Opin Neurol"},{"key":"2633_CR12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/jnc.12277","volume":"127","author":"O Kakhlon","year":"2013","unstructured":"Kakhlon O, Glickstein H, Feinstein N, Liu Y, Baba O, Terashima T, Akman HO, Dimauro S, Lossos A (2013) Polyglucosan neurotoxicity caused by glycogen branching enzyme deficiency can be reversed by inhibition of glycogen synthase. J Neurochem 127:101\u2013113","journal-title":"J Neurochem"},{"key":"2633_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4161\/auto.8.2.19010","volume":"8","author":"R Puri","year":"2012","unstructured":"Puri R, Ganesh S (2012) Autophagy defects in Lafora disease. Cause or consequence? Autophagy 8:289\u2013290","journal-title":"Autophagy"},{"key":"2633_CR14","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1212\/WNL.56.12.1739","volume":"56","author":"N Raben","year":"2001","unstructured":"Raben N, Danon M, Lu N et al (2001) Surprises of genetic engineering. A possible model of polyglucosan body disease. Neurology 56:1739\u20131745","journal-title":"Neurology"},{"key":"2633_CR15","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3390\/ijms18081743","volume":"18","author":"MA Sullivan","year":"2017","unstructured":"Sullivan MA, Nitschke S, Steup M, Minassian B, Nitschke F (2017) Pathogenesis of Lafora disease: transition of soluble glycogen to insoluble polyglucosan. Int J Mol Sci 18:1743","journal-title":"Int J Mol Sci"},{"key":"2633_CR16","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/ana.23963","volume":"74","author":"J Nilsson","year":"2013","unstructured":"Nilsson J, Schoser B, Laforet P, Kalev O, Lindberg C, Romero NB, D\u00e1vila L\u00f3pez M, Akman HO, Wahbi K, Iglseder S, Eggers C, Engel AG, DiMauro S, Oldfors A (2013) Polyglucosan body myopathy caused by defective ubiquitin ligase RBCK1. Ann Neurol 74:914\u2013919","journal-title":"Ann Neurol"},{"key":"2633_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/00005072-199201000-00004","volume":"51","author":"HH Goebel","year":"1992","unstructured":"Goebel HH, Shin YS, Gullotta F et al (1992) Adult polyglucosan body myopathy. J Neuropathol Exp Neurol 51:24\u201335","journal-title":"J Neuropathol Exp Neurol"},{"key":"2633_CR18","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1212\/WNL.31.9.1077","volume":"31","author":"AP Hays","year":"1981","unstructured":"Hays AP, Hallett M, Delfs J, Morris J, Sotrel A, Shevchuk MM, DiMauro S (1981) Muscle phosphofructokinase deficiency: abnormal polysaccharide in a case of late-onset myopathy. Neurology 31:1077\u20131086","journal-title":"Neurology"},{"issue":"ID9523427","key":"2633_CR19","first-page":"6","volume":"2017","author":"H Kadhim","year":"2017","unstructured":"Kadhim H, Segers V, Vilain C et al (2017) First report of fetal cerebral polyglucosan bodies in mucopolysaccharidosis type VII. Case Rep Pediatr 2017(ID9523427):6","journal-title":"Case Rep Pediatr"},{"key":"2633_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF00688332","volume":"74","author":"T Mizutani","year":"1987","unstructured":"Mizutani T, Satoh J, Morimatsu Y (1987) Axonal polyglucosan body in the ventral posterolateral nucleus of the human thalamus in relation to ageing. Acta Neuropathol 74:9\u201312","journal-title":"Acta Neuropathol"},{"key":"2633_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/BF00454906","volume":"86","author":"K Matsumuro","year":"1993","unstructured":"Matsumuro K, Izumo S, Minauchi Y, Inose M, Higuchi I, Osame M (1993) Chronic demyelinating neuropathy and intra-axonal polyglucosan bodies. Acta Neuropathol 86:95\u201399","journal-title":"Acta Neuropathol"},{"key":"2633_CR22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s004010100400","volume":"102","author":"JD Wilson","year":"2001","unstructured":"Wilson JD, Horoupian DS (2001) Bielschowski bodies (Lafora bodies of Bielschowski type): report of a case with Rosenthal fibres in the brain stem. Acta Neuropathol 102:505\u2013509","journal-title":"Acta Neuropathol"},{"key":"2633_CR23","doi-asserted-by":"publisher","first-page":"41807","DOI":"10.1038\/srep41807","volume":"7","author":"E Auge","year":"2017","unstructured":"Auge E, Cabezon I, Pelegri C et al (2017) New perspectives on corpora amylacea in the human brain. Sci Rep 7:41807","journal-title":"Sci Rep"},{"key":"2633_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0022-510X(90)90186-Q","volume":"98","author":"H Yoshikawa","year":"1990","unstructured":"Yoshikawa H, Dyck PJ, Podusio JF et al (1990) Polyglucosan body axonal enlargement increases myelin spiral length but not lamellar number. J Neurol Sci 98:107\u2013117","journal-title":"J Neurol Sci"},{"key":"2633_CR25","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1212\/NXG.0000000000000138","volume":"3","author":"Y Harigaya","year":"2017","unstructured":"Harigaya Y, Matsukawa T, Fujita Y, Mizushima K, Ishiura H, Mitsui J, Morishita S, Shoji M, Ikeda Y, Tsuji S (2017) Novel BGE1 mutation in a Japanese family with adult polyglucosan body disease. Neurol Genet 3:e138","journal-title":"Neurol Genet"},{"key":"2633_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF00698301","volume":"66","author":"GL Mancardi","year":"1985","unstructured":"Mancardi GL, Schenone A, Tabaton M et al (1985) Polyglucosan bodies in the sural nerve of a diabetic patient with polyneuropathy. Acta Neuropathol 66:83\u201386","journal-title":"Acta Neuropathol"},{"key":"2633_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/BF00687012","volume":"65","author":"O Komure","year":"1985","unstructured":"Komure O, Ichikawa K, Tsutsumi A, Hiyama K, Fujioka A (1985) Intraxonal polysaccharide deposits in the peripheral nerve seen in adult polysaccharide storage myopathy. Acta Neuropathol 65:300\u2013304","journal-title":"Acta Neuropathol"},{"key":"2633_CR28","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/BF00294618","volume":"80","author":"HL Busard","year":"1990","unstructured":"Busard HL, Gabreels-Festen AA, Van\u2019t Hof MA et al (1990) Polyglucosan bodies in sural nerve biopsies. Acta Neuropathol 80:554\u2013557","journal-title":"Acta Neuropathol"},{"key":"2633_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3143\/geriatrics.20.330","volume":"20","author":"M Tomonaga","year":"1983","unstructured":"Tomonaga M, Sait M, Nagasawa H et al (1983) Polyglucosan body observed in intramuscular nerve and ageing. Nippon Igokukei Zasshi 20:330\u2013339","journal-title":"Nippon Igokukei Zasshi"},{"key":"2633_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jns.2015.11.053","volume":"360","author":"JQ Lu","year":"2016","unstructured":"Lu JQ, Phan C, Zochodne D, Yan C (2016) Polyglucosan bodies in intramuscular nerves: association with muscle fibre denervation atrophy. J Neurol Sci 360:84\u201387","journal-title":"J Neurol Sci"},{"key":"2633_CR31","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/BF00687891","volume":"77","author":"RA Bernsen","year":"1989","unstructured":"Bernsen RA, Busard HJ, Ter Laak FJ et al (1989) Polyglucosan bodies in intramuscular motor nerves. Acta Neuropathol 77:629\u2013633","journal-title":"Acta Neuropathol"},{"key":"2633_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/mus.25017","volume":"53","author":"LV Furtado","year":"2016","unstructured":"Furtado LV, Kadri S, Wurst MN, Long BC, Segal JP, Pytel P (2016) Polyglucosan bodies in intramuscular nerve branches are a poor predictor of GBE1 mutation and adult polyglucosan body disease. Muscle Nerve 53:473\u2013475","journal-title":"Muscle Nerve"},{"key":"2633_CR33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1136\/jnnp.23.4.302","volume":"23","author":"JM McDonald-Holmes","year":"1960","unstructured":"McDonald-Holmes JM, Houghton CR, Woolf AL (1960) A myopathy presenting in adult life with features suggestive of glycogen storage disease. J Neurol Neurosurg Psychiatry 23:302\u2013311","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2633_CR34","doi-asserted-by":"crossref","unstructured":"Pellissier JF, De Barsy T, Bille J et al (1981) Polysaccharide (amylopectin-like) storage myopathy. Histochemical, ultrastructural, and biochemical studies. In: Jellinger K., Gullotta F., Mossakowski M. (eds) Experimental and clinical neuropathology. Acta Neuropathologica Supplementum, vol 7. Springer, Berlin, Heidelberg","DOI":"10.1007\/978-3-642-81553-9_84"},{"key":"2633_CR35","first-page":"977","volume":"111","author":"GM Greene","year":"1987","unstructured":"Greene GM, Weldon DC, Ferrans VJ et al (1987) Juvenile polysaccharidosis with cardioskeletal myopathy. Arch Pathol Lab Med 111:977\u2013982","journal-title":"Arch Pathol Lab Med"},{"key":"2633_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mus.880110411","volume":"11","author":"AJ Thompson","year":"1988","unstructured":"Thompson AJ, Swash M, Cox EL, Ingram DA, Gray A, Schwartz MS (1988) Polysaccharide storage myopathy. Muscle Nerve 11:349\u2013355","journal-title":"Muscle Nerve"},{"key":"2633_CR37","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0960-8966(06)80014-3","volume":"2","author":"P Tonin","year":"1992","unstructured":"Tonin P, Tomelleri G, Vio M, Rizzuto N (1992) Polyglucosan body myopathy: a new case. Neuromuscul Disord 2:419\u2013422","journal-title":"Neuromuscul Disord"},{"key":"2633_CR38","first-page":"697","volume":"148","author":"E Calore","year":"1992","unstructured":"Calore E, Pellissier JF, Figarella-Branger D et al (1992) Polysaccharide amylopectin-type storage myopathy. Rev Neurol (Paris) 148:697\u2013703","journal-title":"Rev Neurol (Paris)"},{"key":"2633_CR39","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s00115-006-2184-x","volume":"77","author":"M Jeub","year":"2006","unstructured":"Jeub M, Kappes-Horn K, Kornblum C, Fischer D (2006) Spatmanifestation einer polyglykosan-korpermyopathie. Nervenarzt 77:1487\u20131491","journal-title":"Nervenarzt"},{"key":"2633_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ymgme.2008.07.005","volume":"95","author":"B Schoser","year":"2008","unstructured":"Schoser B, Bruno C, Schneider HC, Shin YS, Podskarbi T, Goldfarb L, M\u00fcller-Felber W, M\u00fcller-H\u00f6cker J (2008) Unclassified polysaccharidosis of the heart and skeletal muscle in siblings. Mol Genet Metab 95:52\u201358","journal-title":"Mol Genet Metab"},{"key":"2633_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1399-3046.2005.00282.x","volume":"9","author":"BB Das","year":"2005","unstructured":"Das BB, Narkewicz MR, Sokol RJ, Chen YT, Bali D, Li SC, Matthews MR, Mierau GW, Ivy DD (2005) Amylopectinosis disease isolated to the heart with normal glycogen branching enzyme activity and gene sequence. Pediatr Transplant 9:261\u2013265","journal-title":"Pediatr Transplant"},{"key":"2633_CR42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10545-016-9978-1","volume":"40","author":"C Hedberg-Oldfors","year":"2017","unstructured":"Hedberg-Oldfors C, Glamuzina E, Ruygrok P, Anderson LJ, Elliott P, Watkinson O, Occleshaw C, Abernathy M, Turner C, Kingston N, Murphy E, Oldfors A (2017) Cardiomyopathy as presenting sign of glycogenin-1 deficiency-report of three cases and review of the literature. J Inherit Metab Dis 40:139\u2013149","journal-title":"J Inherit Metab Dis"},{"key":"2633_CR43","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/ana.410290420","volume":"29","author":"HL Busard","year":"1991","unstructured":"Busard HL, Gabreels-Festen AA, Renier WO et al (1991) Adult polyglucosan body disease: the diagnostic value of axilla skin biopsy. Ann Neurol 29:448\u2013451","journal-title":"Ann Neurol"},{"key":"2633_CR44","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nn1998","volume":"10","author":"D Vilchez","year":"2007","unstructured":"Vilchez D, Ros S, Cifuentes D, Pujadas L, Vall\u00e8s J, Garc\u00eda-Fojeda B, Criado-Garc\u00eda O, Fern\u00e1ndez-S\u00e1nchez E, Medra\u00f1o-Fern\u00e1ndez I, Dom\u00ednguez J, Garc\u00eda-Rocha M, Soriano E, Rodr\u00edguez de C\u00f3rdoba S, Guinovart JJ (2007) Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat Neurosci 10:1407\u20131413","journal-title":"Nat Neurosci"},{"key":"2633_CR45","doi-asserted-by":"publisher","first-page":"701","DOI":"10.4161\/auto.19522","volume":"8","author":"E Knecht","year":"2012","unstructured":"Knecht E, Criado-Garcia O, Aguado C et al (2012) Malin knockout mice support a primary role of autophagy in the pathogenesis of Lafora disease. Autophagy 8:701\u2013703","journal-title":"Autophagy"},{"key":"2633_CR46","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1172\/JCI0214571","volume":"109","author":"M Arad","year":"2002","unstructured":"Arad M, Benson DW, Perez-Atayde AR, McKenna WJ, Sparks EA, Kanter RJ, McGarry K, Seidman JG, Seidman CE (2002) Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest 109:357\u2013362","journal-title":"J Clin Invest"},{"key":"2633_CR47","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jchf.2018.02.010","volume":"6","author":"JB Geske","year":"2018","unstructured":"Geske JB, Ommen SR, Gersh BJ (2018) Hypertrophic cardiomyopathy. Clinical update JACC Heart failure 6:364\u2013375","journal-title":"Clinical update JACC Heart failure"},{"key":"2633_CR48","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1161\/hc5001.102111","volume":"104","author":"MH Gollob","year":"2001","unstructured":"Gollob MH, Seger JJ, Gollob TN, Tapscott T, Gonzales O, Bachinski L, Roberts R (2001) Novel PRKAG2 mutations responsible for the genetic syndrome of ventricular pre-excitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation 104:3030\u20133033","journal-title":"Circulation"},{"key":"2633_CR49","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1056\/NEJMoa033349","volume":"352","author":"M Arad","year":"2005","unstructured":"Arad M, Maron BJ, Gorham JM, Johnson WH Jr, Saul JP, Perez-Atayde AR, Spirito P, Wright GB, Kanter RJ, Seidman CE, Seidman JG (2005) Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 352:362\u2013372","journal-title":"N Engl J Med"},{"key":"2633_CR50","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1086\/430840","volume":"76","author":"B Burwinkel","year":"2005","unstructured":"Burwinkel B, Scott JW, Buhrer C et al (2005) Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma-2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. Am J Hum Genet 76:1034\u20131049","journal-title":"Am J Hum Genet"},{"key":"2633_CR51","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1007\/s00246-009-9521-3","volume":"30","author":"BP Kelly","year":"2009","unstructured":"Kelly BP, Russell MW, Hennessy JR, Ensing GJ (2009) Severe hypertrophic cardiomyopathy in an infant with a novel PRKAG2 gene mutation: potential differences between infantile and adult onset presentation. Pediatr Cardiol 30:1176\u20131179","journal-title":"Pediatr Cardiol"},{"key":"2633_CR52","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/hmg\/10.11.1215","volume":"10","author":"E Blair","year":"2001","unstructured":"Blair E, Redwood C, Ashrafian H et al (2001) Mutations in the \u03b32 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy; evidence for the central role of energy compromise in diverse pathogenesis. Hum Mol Genet 10:1215\u20131220","journal-title":"Hum Mol Genet"},{"key":"2633_CR53","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.nmd.2005.12.004","volume":"16","author":"P Laforet","year":"2006","unstructured":"Laforet P, Richard P, Said MA et al (2006) A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis. Neuromuscul Disord 16:178\u2013182","journal-title":"Neuromuscul Disord"},{"key":"2633_CR54","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1172\/JCI113229","volume":"80","author":"S Vora","year":"1987","unstructured":"Vora S, DiMauro S, Spear D, Harker D, Danon MJ (1987) Characterization of the enzymatic defect in late-onset muscle PFK deficiency. J Clin Invest 80:1479\u20131485","journal-title":"J Clin Invest"},{"key":"2633_CR55","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jns.2012.01.027","volume":"316","author":"E Malfatti","year":"2012","unstructured":"Malfatti E, Birouk N, Romero NB, Piraud M, Petit FM, Hogrel JY, Lafor\u00eat P (2012) Juvenile-onset permanent weakness in muscle phosphofructokinase deficiency. J Neurol Sci 316:173\u2013177","journal-title":"J Neurol Sci"},{"key":"2633_CR56","first-page":"305","volume":"55","author":"JB Sherman","year":"1994","unstructured":"Sherman JB, Raben N, Nicastri C et al (1994) Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenosis type VII and their population frequency. Am J Hum Genet 55:305\u2013313","journal-title":"Am J Hum Genet"},{"key":"2633_CR57","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0072-9752(07)86007-6","volume":"86","author":"S DiMauro","year":"2007","unstructured":"DiMauro S, Akman O, Hays AP (2007) Disorders of carbohydrate metabolism. Handb Clin Neurol 86:167\u2013182","journal-title":"Handb Clin Neurol"},{"key":"2633_CR58","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/ni.2457","volume":"13","author":"B Boisson","year":"2012","unstructured":"Boisson B, Laplantine E, Prando C, Giliani S, Israelsson E, Xu Z, Abhyankar A, Isra\u00ebl L, Trevejo-Nunez G, Bogunovic D, Cepika AM, MacDuff D, Chrabieh M, Hubeau M, Bajolle F, Debr\u00e9 M, Mazzolari E, Vairo D, Agou F, Virgin HW, Bossuyt X, Rambaud C, Facchetti F, Bonnet D, Quartier P, Fournet JC, Pascual V, Chaussabel D, Notarangelo LD, Puel A, Isra\u00ebl A, Casanova JL, Picard C (2012) Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat Immunol 13:1178\u20131188","journal-title":"Nat Immunol"},{"key":"2633_CR59","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1101\/gad.1228704","volume":"18","author":"MS Hayden","year":"2004","unstructured":"Hayden MS, Ghosh S (2004) Signalling to NF-kappa B. Genes Dev 18:2195\u20132224","journal-title":"Genes Dev"},{"key":"2633_CR60","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s00415-017-8710-x","volume":"265","author":"M Krenn","year":"2018","unstructured":"Krenn M, Salzer E, Simonitsch-Klupp I, Rath J, Wagner M, Haack TB, Strom TM, Sch\u00e4nzer A, Kilimann MW, Schmidt RLJ, Schmetterer KG, Zimprich A, Boztug K, Hahn A, Zimprich F (2018) Mutations outside the N-terminal part of RBCK1 may cause polyglucosan body myopathy with immunological dysfunction: expanding the genotype-phenotype spectrum. J Neurol 265:394\u2013401","journal-title":"J Neurol"},{"key":"2633_CR61","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/gm471","volume":"5","author":"K Wang","year":"2013","unstructured":"Wang K, Kim C, Bradfield J, Guo Y, Toskala E, Otieno FG, Hou C, Thomas K, Cardinale C, Lyon GJ, Golhar R, Hakonarson H (2013) Whole-genome DNA\/RNA sequencing identifies truncating mutations in RBCK1 in a novel Mendelian disease with neuromuscular and cardiac involvement. Genome Med 5:67\u201374","journal-title":"Genome Med"},{"key":"2633_CR62","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/WCO.0000000000000484","volume":"30","author":"P Laforet","year":"2017","unstructured":"Laforet P, Malfatti E, Vissing J (2017) Update on new muscle glycogenosis. Curr Opin Neurol 30:449\u2013456","journal-title":"Curr Opin Neurol"},{"key":"2633_CR63","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1399-3046.2007.00803.x","volume":"12","author":"MK Davis","year":"2008","unstructured":"Davis MK, Weinstein DA (2008) Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk\/benefit of this procedure. Pediatr Transplant 12:137\u2013145","journal-title":"Pediatr Transplant"},{"key":"2633_CR64","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF01799348","volume":"19","author":"A McConkie-Rosell","year":"1996","unstructured":"McConkie-Rosell A, Wilson C, Piccoli DA, Boyle J, de Clue T, Kishnani P, Shen JJ, Boney A, Brown B, Chen YT (1996) Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease. J Inherit Metab Dis 19:51\u201358","journal-title":"J Inherit Metab Dis"},{"key":"2633_CR65","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1212\/01.WNL.0000138429.11433.0D","volume":"63","author":"C Bruno","year":"2004","unstructured":"Bruno C, Van Diggelen OP, Cassandrini D et al (2004) Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV). Neurology 63:1053\u20131058","journal-title":"Neurology"},{"key":"2633_CR66","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.nmd.2003.12.006","volume":"14","author":"SKH Tay","year":"2004","unstructured":"Tay SKH, Akman HO, Chung WK, Pike MG, Muntoni F, Hays AP, Shanske S, Valberg SJ, Mickelson JR, Tanji K, DiMauro S (2004) Fatal infantile neuromuscular presentation of glycogen storage disease type IV. Neuromuscul Disord 14:253\u2013260","journal-title":"Neuromuscul Disord"},{"key":"2633_CR67","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00401-008-0417-8","volume":"116","author":"KW Nolte","year":"2008","unstructured":"Nolte KW, Janecke AR, Vorgerd M, Weis J, Schr\u00f6der JM (2008) Congenital type IV glycogenosis: the spectrum of pleomorphic polyglucosan bodies in muscle, nerve, and spinal cord with two novel mutations in the GBE1 gene. Acta Neuropathol 116:491\u2013506","journal-title":"Acta Neuropathol"},{"key":"2633_CR68","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.nmd.2010.07.275","volume":"20","author":"AL Taratuto","year":"2010","unstructured":"Taratuto AL, Akman HO, Saccoliti M, Riudavets M, Arakaki N, Mesa L, Sevlever G, Goebel H, DiMauro S (2010) Branching enzyme deficiency\/glycogenosis storage disease type IV presenting as a severe congenital hypotonia: muscle biopsy and autopsy findings, biochemical and molecular genetic studies. Neuromuscul Disord 20:783\u2013790","journal-title":"Neuromuscul Disord"},{"issue":"S1","key":"2633_CR69","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10545-009-1134-8","volume":"32","author":"C Lamperti","year":"2009","unstructured":"Lamperti C, Salani S, Lucchiari S, Bordoni A, Ripolone M, Fagiolari G, Fruguglietti ME, Crugnola V, Colombo C, Cappellini A, Prelle A, Bresolin N, Comi GP, Moggio M (2009) Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of glycogen storage disease type IV associated with a new mutation in GBE1 gene. J Inherit Metab Dis 32(S1):161\u2013168","journal-title":"J Inherit Metab Dis"},{"key":"2633_CR70","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.nmd.2016.07.005","volume":"26","author":"E Malfatti","year":"2016","unstructured":"Malfatti E, Barnerias C, Hedberg-Oldfors C et al (2016) A novel neuromuscular form of glycogen storage disease type IV with arthrogryposis, spinal stiffness and rare polyglucosan bodies in muscle. Neuromuscul Disord 26:81\u201387","journal-title":"Neuromuscul Disord"},{"key":"2633_CR71","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0022-3476(87)80341-4","volume":"11","author":"S Servidei","year":"1987","unstructured":"Servidei S, Riepe RE, Langston C et al (1987) Severe cardiomyopathy in branching enzyme deficiency. J Pediatr 11:51\u201356","journal-title":"J Pediatr"},{"key":"2633_CR72","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1093\/oxfordjournals.eurheartj.a060797","volume":"16","author":"S Nase","year":"1995","unstructured":"Nase S, Kunze KP, Sigmund M et al (1995) A new variant of type IV glycogenosis with primary cardiac manifestation and complete branching enzyme deficiency. In vivo detection by heart muscle biopsy. Eur Heart J 16:1698\u20131704","journal-title":"Eur Heart J"},{"key":"2633_CR73","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s003920050361","volume":"88","author":"R Ewert","year":"1999","unstructured":"Ewert R, Gulijew A, Wensel R, Dandel M, Hummel M, Vogel M, Meyer R, Hetzer R (1999) Die glykogenose type IV seltene ursache einer kardiomyopathies\u2014bericht einer erfolgreichen herztransplantation. Z Kardiol 88:850\u2013856","journal-title":"Z Kardiol"},{"key":"2633_CR74","first-page":"1124","volume":"23","author":"A De La Blanchardiere","year":"1994","unstructured":"De La Blanchardiere A, Vayssier C, Duboc D et al (1994) Severe cardiomyopathy revealing amylopectinosis. Two cases in adolescents from the same family. Presse Med 23:1124\u20131127","journal-title":"Presse Med"},{"key":"2633_CR75","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0387-7604(12)80277-4","volume":"14","author":"E Reusche","year":"1992","unstructured":"Reusche E, Aksu F, Goebel HH, Shin YS, Yokota T, Reichmann H (1992) A mild juvenile variant of type IV glycogenosis. Brain Dev 14:36\u201343","journal-title":"Brain Dev"},{"key":"2633_CR76","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/brain\/103.2.315","volume":"103","author":"Y Robitaille","year":"1980","unstructured":"Robitaille Y, Carpenter S, Karpati G et al (1980) A distinct form of adult polyglycosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of 4 cases and a review of the occurrence of polyglycosan bodies in other conditions such as Lafora\u2019s disease and normal ageing. Brain 103:315\u2013336","journal-title":"Brain"},{"key":"2633_CR77","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1212\/WNL.43.4.785","volume":"43","author":"TD McDonald","year":"1993","unstructured":"McDonald TD, Faust PL, Bruno C et al (1993) Polyglucosan body disease simulating amyotrophic lateral sclerosis. Neurology 43:785\u2013790","journal-title":"Neurology"},{"key":"2633_CR78","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/mus.20720","volume":"35","author":"S Vucic","year":"2007","unstructured":"Vucic S, Pamphlett R, Willis EJ et al (2007) Polyglucosan body disease myopathy: an unusual presentation. Muscle Nerve 35:536\u2013539","journal-title":"Muscle Nerve"},{"key":"2633_CR79","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/ana.410440604","volume":"44","author":"A Lossos","year":"1998","unstructured":"Lossos A, Meiner Z, Barash V, Soffer D, Schlesinger I, Abramsky O, Argov Z, Shpitzen S, Meiner V (1998) Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Try329Ser mutations in the glycogen-branching enzyme gene. Ann Neurol 44:867\u2013872","journal-title":"Ann Neurol"},{"key":"2633_CR80","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bbrc.2012.08.089","volume":"426","author":"A Hussain","year":"2012","unstructured":"Hussain A, Armistead J, Gushulak L, Kruck C, Pind S, Triggs-Raine B, Natowicz MR (2012) The adult polyglucosan body disease mutation GBE1 c.1076A>C occurs at high frequency in persons of Ashkenazi Jewish background. Biochem Biophys Res Commun 426:286\u2013288","journal-title":"Biochem Biophys Res Commun"},{"key":"2633_CR81","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1006\/bbrc.1996.0359","volume":"220","author":"F Barbetti","year":"1996","unstructured":"Barbetti F, Rocchi M, Bossolasco M, Cordera R, Sbraccia P, Finelli P, Consalez GG (1996) The human skeletal muscle glycogenin gene: cDNA, tissue expression, and chromosomal localization. Biochem Biophys Res Commun 220:72\u201377","journal-title":"Biochem Biophys Res Commun"},{"key":"2633_CR82","doi-asserted-by":"publisher","first-page":"27589","DOI":"10.1074\/jbc.272.44.27589","volume":"272","author":"J Mu","year":"1997","unstructured":"Mu J, Skurat AV, Roach PJ (1997) Glycogenin-2, a novel self-glucosylation protein involved in liver glycogen biosynthesis. J Biol Chem 272:27589\u201327597","journal-title":"J Biol Chem"},{"key":"2633_CR83","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00439-013-1372-6","volume":"13","author":"E Imagawa","year":"2014","unstructured":"Imagawa E, Osaka H, Yamashita A et al (2014) A hemizygous GYG2 mutation and Leigh syndrome: a possible link? Hum Genet 13:225\u2013234","journal-title":"Hum Genet"},{"key":"2633_CR84","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.abb.2006.09.024","volume":"456","author":"AV Skurat","year":"2006","unstructured":"Skurat AV, Dietrich AD, Roach PJ (2006) Interaction between glycogenin and glycogen synthase. Arch Biochem Biophys 456:93\u201397","journal-title":"Arch Biochem Biophys"},{"key":"2633_CR85","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1210\/jc.2017-00399","volume":"102","author":"C Ruiz-Ruiz","year":"2017","unstructured":"Krag TO, Ruiz-Ruiz C, Vissing J (2017) Glycogen synthesis in glycogenin 1 deficient patients; a role for glycogenin 2 in muscle. J Clin Endocrinol Metab 102:2690\u20132700","journal-title":"J Clin Endocrinol Metab"},{"key":"2633_CR86","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.bbapap.2013.11.002","volume":"1844","author":"J Nilsson","year":"2014","unstructured":"Nilsson J, Halim A, Larsson E, Moslemi AR, Oldfors A, Larson G, Nilsson J (2014) LC-MS\/MS characterization of combined glycogenin-1 and glycogenin-2 enzymatic activities reveals their self-glucosylation preferences. Biochim Biophys Acta 1844:398\u2013405","journal-title":"Biochim Biophys Acta"},{"key":"2633_CR87","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1056\/NEJMoa0900661","volume":"362","author":"AR Moslemi","year":"2010","unstructured":"Moslemi AR, Lindberg C, Nilsson J, Tajsharghi H, Andersson B, Oldfors A (2010) Glycogenin-1 deficiency and inactivated priming of glycogen synthesis. N Engl J Med 362:1203\u20131210","journal-title":"N Engl J Med"},{"key":"2633_CR88","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.bbadis.2011.11.017","volume":"1822","author":"J Nilsson","year":"2012","unstructured":"Nilsson J, Halim A, Moslemi A et al (2012) Molecular pathogenesis of a new glycogenosis caused by a glycogenin-1 mutation. Biochim Biophys Acta 1822:493\u2013499","journal-title":"Biochim Biophys Acta"},{"key":"2633_CR89","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ana.24284","volume":"76","author":"E Malfatti","year":"2014","unstructured":"Malfatti E, Nilsson J, Hedberg-Oldfors C, Hernandez-Lain A, Michel F, Dominguez-Gonzalez C, Viennet G, Akman HO, Kornblum C, van den Bergh P, Romero NB, Engel AG, DiMauro S, Oldfors A (2014) A new muscle glycogen storage disease associated with glycogenin-1 deficiency. Ann Neurol 76:891\u2013898","journal-title":"Ann Neurol"},{"key":"2633_CR90","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/jnnp-2015-310553","volume":"87","author":"I Colombo","year":"2016","unstructured":"Colombo I, Pagliarani S, Testolin S, Cinnante CM, Fagiolari G, Ciscato P, Bordoni A, Fortunato F, Magri F, Previtali SC, Velardo D, Sciacco M, Comi GP, Moggio M (2016) Longitudinal follow-up and muscle MRI pattern of two siblings with polyglucosan bodies myopathy due to glycogenin-1 mutation. J Neurol Neurosurg Psychiatry 87:797\u2013800","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2633_CR91","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.nmd.2015.07.007","volume":"25","author":"S Luo","year":"2015","unstructured":"Luo S, Zhu W, Yue D, Lin J, Wang Y, Zhu Z, Qiu W, Lu J, Hedberg-Oldfors C, Oldfors A, Zhao C (2015) Muscle pathology and whole-body MRI in a polyglucosan myopathy associated with a novel glycogenin-1 mutation. Neuromuscul Disord 25:780\u2013785","journal-title":"Neuromuscul Disord"},{"key":"2633_CR92","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.nmd.2015.10.012","volume":"26","author":"HO Akman","year":"2016","unstructured":"Akman HO, Aykit Y, Amuk OC, Malfatti E, Romero NB, Maioli MA, Piras R, DiMauro S, Marrosu G (2016) Late-onset polyglucosan body myopathy in five patients with a homozygous mutation in GYG1. Neuromuscul Disord 26:16\u201320","journal-title":"Neuromuscul Disord"},{"key":"2633_CR93","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.nmd.2018.01.002","volume":"28","author":"M Desikan","year":"2018","unstructured":"Desikan M, Scalco RS, Manole A, Gardiner AR, Schapira AH, Lachmann RH, Houlden H, Holton JL, Phadke R, Quinlivan R (2018) GYG1 causing progressive limb girdle myopathy with onset during teenage years (polyglucosan body myopathy 2). Neuromuscul Disord 28:346\u2013349","journal-title":"Neuromuscul Disord"},{"key":"2633_CR94","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1007\/s00415-016-8268-z","volume":"263","author":"G Tasca","year":"2016","unstructured":"Tasca G, Fattori F, Monforte M, Hedberg-Oldfors C, Sabatelli M, Udd B, Boldrini R, Bertini E, Ricci E, Oldfors A (2016) Start codon mutation of GYG1 causing late-onset polyglucosan body myopathy with nemaline bodies. J Neurol 263:2133\u20132135","journal-title":"J Neurol"},{"key":"2633_CR95","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1212\/NXG.0000000000000208","volume":"3","author":"R Ben Yaou","year":"2017","unstructured":"Ben Yaou R, Hubert A, Nelson I, Dahlqvist JR, Gaist D, Streichenberger N, Beuvin M, Krahn M, Petiot P, Parisot F, Michel F, Malfatti E, Romero N, Carlier RY, Eymard B, Labrune P, Duno M, Krag T, Cerino M, Bartoli M, Bonne G, Vissing J, Laforet P, Petit FM (2017) Clinical heterogeneity and phenotype\/genotype findings in 5 families with GYG1 deficiency. Neurol Genet 3:e208","journal-title":"Neurol Genet"},{"key":"2633_CR96","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/ane.12865","volume":"137","author":"C Hedberg-Oldfors","year":"2018","unstructured":"Hedberg-Oldfors C, Mensch A, Visuttijai K, Stoltenburg G, Stoevesandt D, Kraya T, Oldfors A, Zierz S (2018) Polyglucosan myopathy and functional characterization of a novel GYG1 mutation. Acta Neurol Scand 137:308\u2013315","journal-title":"Acta Neurol Scand"},{"key":"2633_CR97","doi-asserted-by":"publisher","first-page":"E122","DOI":"10.1002\/mus.26030","volume":"57","author":"T Stojkovic","year":"2018","unstructured":"Stojkovic T, Chanut A, Laforet P et al (2018) Severe asymmetric muscle weakness revealing glycogenin-1 polyglucosan body myopathy. Muscle Nerve 57:E122\u2013E124","journal-title":"Muscle Nerve"},{"issue":"1","key":"2633_CR98","first-page":"54","volume":"34","author":"F Invernizzi","year":"2015","unstructured":"Invernizzi F, Morandi L, Mora M et al (2015) An Italian cohort of patients with mutations in glycogenin-1 gene. Acta Myol 34(1):54 (abs)","journal-title":"Acta Myol"},{"key":"2633_CR99","first-page":"271","volume":"7","author":"J Weis","year":"1988","unstructured":"Weis J, Schroder JM (1988) Adult polyglucosan body myopathy with subclinical peripheral neuropathy: case report and review of diseases associated with polyglucosan body accumulation. Clin Neuropathol 7:271\u2013279","journal-title":"Clin Neuropathol"},{"key":"2633_CR100","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000021","volume":"1","author":"M Fanin","year":"2015","unstructured":"Fanin M, Torella A, Savarese M, Nigro V, Angelini C (2015) GYG1 gene mutations in a family with polyglucosan body myopathy. Neurol Genet 1:e21","journal-title":"Neurol Genet"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02633-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-019-02633-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02633-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T05:56:03Z","timestamp":1610690163000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-019-02633-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,30]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2633"],"URL":"https:\/\/doi.org\/10.1007\/s00428-019-02633-6","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,30]]},"assertion":[{"value":"12 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}